Stay updated on LY3375880 in Moderate-Severe Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the LY3375880 in Moderate-Severe Atopic Dermatitis Clinical Trial page.

Latest updates to the LY3375880 in Moderate-Severe Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check49 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check56 days agoChange DetectedA new study on LY3375880 for treating moderate-to-severe atopic dermatitis has been added, along with helpful links from Eli Lilly and Company.SummaryDifference0.6%
- Check63 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check70 days agoChange DetectedThe website has added a new intervention type in version 2.14.0 while removing the previous intervention type and a study link related to LY3375880 in version 2.13.3.SummaryDifference0.8%
Stay in the know with updates to LY3375880 in Moderate-Severe Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3375880 in Moderate-Severe Atopic Dermatitis Clinical Trial page.